Radiation therapy equipment developer Elekta has received U.S. Food and Drug Administration 510(k) marketing clearance for its Elekta Beam Modulator, a multileaf collimator designed for use with its medical linear accelerators.
The device shapes the radiation beam to more closely conform to the exact shape of the tumor, thereby allowing greater accuracy and smaller treatment fields, according to the Stockholm, Sweden-based firm.
By AuntMinnie.com staff writers
February 24, 2005
Related Reading
Elekta nets UCSD MEG sale, February 22, 2005
Elekta scores global installations, February 14, 2005
Elekta partners with Swedish Cancer Institute, February 10, 2005
Elekta to acquire Impac, January 18, 2005
Elekta taps PerkinElmer, October 25, 2004
Copyright © 2005 AuntMinnie.com
